• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    3.71 0.00(0.00%) Mar 27, 4:00PM EDT
    |After Hours : 3.71 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:3.71
    Open:3.71
    Bid:3.68 x 5000
    Ask:4.04 x 200
    1y Target Est:7.00
    Beta:-0.88
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:3.67 - 3.81
    52wk Range:3.04 - 5.48
    Volume:623,615
    Avg Vol (3m):1,025,390
    Market Cap:346.47M
    P/E (ttm):N/A
    EPS (ttm):-0.51
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMU 0.00%346.47M
    BIIBUp 0.22%100.85B
    GSKUp 0.77%113.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):78.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.52
    Quarterly EPS Est (Mar-15) :-0.13
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback